Antimicrobial Resistance Patterns and Virulence Factors of Enterococci Isolates in Hospitalized Burn Patients

Overview

Journal BMC Res Notes

Publisher Biomed Central

Specialties Biology
General Medicine

Date 2018 Jan 3

PMID 29291749

Citations 12

Authors

Leili Shokoohizadeh

Alireza Ekrami

Maryam Labibzadeh

Liaqat Ali

Seyed Mohammad Alavi

Affiliations

Soon will be listed here.

Abstract

Objective: The objective of this study was to determine the frequency of the antimicrobial resistance and genes encoding virulence factors of enterococci isolated in hospitalized burn patients in a major burn center in Ahvaz, southwest of Iran. A total of 340 bacterial isolates were collected from the burn center from February 2014 to February 2015. The antimicrobial susceptibility and MIC of vancomycin were determined using the disk diffusion and micro-agar dilution techniques. The genus and species-specific genes, potential virulence genes, and vanA and vanB genes were detected by polymerase chain reaction.

Results: According to our results, out of the 340 bacterial isolates, 16.4% (n = 56) were identified as enterococci. Out of the 56 enterococcal isolates, 35 (62.5%) were Enterococcus faecalis and 21 (37.5%) were Enterococcus faecium. More than 20% (n = 5) of E. faecium demonstrated resistance to vancomycin. The gelE and asa genes were the most prevalent virulence genes in E. faecalis (48.5%) and E. faecium (43%) isolates. The emergence of vancomycin resistant E. faecium strains which have several virulence factors should be considered as a major cause of concern for burn centers. Control and management of infections induced by enterococci should be regarded as highly important in burn patients.

Citing Articles

Integrating narrative and bibliometric approaches to examine factors and impacts of tuberculosis treatment non-compliance.

Santosa A, Juniarti N, Pahria T, Susanti R Multidiscip Respir Med. 2025; 20.

PMID: 40017294 PMC: 11875689. DOI: 10.5826/mrm.2025.1016.

Prevalence of Opportunistic Infections and Determinants Among HIV-Positive Patients in Ethiopia: A Systematic Review and Meta-Analysis.

Aemiro A, Girma A, Beletew D Health Sci Rep. 2025; 8(2):e70418.

PMID: 39906241 PMC: 11790600. DOI: 10.1002/hsr2.70418.

Gender characteristics, social determinants, and seasonal patterns of malaria incidence, relapse, and mortality in Sistan and Baluchistan province and other province of Iran: A systematic review and meta-analysis.

Khazaee-Pool M, Moosazadeh M, Asadi-Aliabadi M, Yazdani F, Ponnet K BMC Infect Dis. 2025; 25(1):154.

PMID: 39893422 PMC: 11787763. DOI: 10.1186/s12879-025-10542-0.

Prevalence of diabetic retinopathy and its associated factors among adults in East African countries: A systematic review and meta-analysis.

Abuhay H, Tesfie T, Alemayehu M, Agimas M, Yismaw G, Alemu G PLoS One. 2025; 20(1):e0316160.

PMID: 39888910 PMC: 11785277. DOI: 10.1371/journal.pone.0316160.

A study on red potato peel ( Red Holland): characterization, composition and formulation of tablet using different drying techniques.

Tripathi D, Kumari M, Chauhan A, Kumar D, Dhondale M J Food Sci Technol. 2025; 62(1):122-133.

PMID: 39867618 PMC: 11754582. DOI: 10.1007/s13197-024-06015-y.

References

Kariyama R, Mitsuhata R, Chow J, Clewell D, Kumon H . Simple and reliable multiplex PCR assay for surveillance isolates of vancomycin-resistant enterococci. J Clin Microbiol. 2000; 38(8):3092-5. PMC: 87194. DOI: 10.1128/JCM.38.8.3092-3095.2000. View

Emaneini M, Aligholi M, Aminshahi M . Characterization of glycopeptides, aminoglycosides and macrolide resistance among Enterococcus faecalis and Enterococcus faecium isolates from hospitals in Tehran. Pol J Microbiol. 2008; 57(2):173-8. View

DAvignon L, Hogan B, Murray C, Loo F, Hospenthal D, Cancio L . Contribution of bacterial and viral infections to attributable mortality in patients with severe burns: an autopsy series. Burns. 2010; 36(6):773-9. DOI: 10.1016/j.burns.2009.11.007. View

Sharifi Y, Hasani A, Ghotaslou R, Varshochi M, Hasani A, Aghazadeh M . Survey of Virulence Determinants among Vancomycin Resistant Enterococcus faecalis and Enterococcus faecium Isolated from Clinical Specimens of Hospitalized Patients of North west of Iran. Open Microbiol J. 2012; 6:34-9. PMC: 3349944. DOI: 10.2174/1874285801206010034. View

Mundy L, Sahm D, Gilmore M . Relationships between enterococcal virulence and antimicrobial resistance. Clin Microbiol Rev. 2000; 13(4):513-22. PMC: 88945. DOI: 10.1128/CMR.13.4.513. View

Falk P, Winnike J, Woodmansee C, Desai M, Mayhall C . Outbreak of vancomycin-resistant enterococci in a burn unit. Infect Control Hosp Epidemiol. 2000; 21(9):575-82. DOI: 10.1086/501806. View

Sood S, Malhotra M, Das B, Kapil A . Enterococcal infections & antimicrobial resistance. Indian J Med Res. 2008; 128(2):111-21. View

Heidari H, Emaneini M, Dabiri H, Jabalameli F . Virulence factors, antimicrobial resistance pattern and molecular analysis of Enterococcal strains isolated from burn patients. Microb Pathog. 2015; 90:93-7. DOI: 10.1016/j.micpath.2015.11.017. View

Glen Mayhall C . The epidemiology of burn wound infections: then and now. Clin Infect Dis. 2003; 37(4):543-50. DOI: 10.1086/376993. View

10.

Vankerckhoven V, Van Autgaerden T, Vael C, Lammens C, Chapelle S, Rossi R . Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp, and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium. J Clin Microbiol. 2004; 42(10):4473-9. PMC: 522368. DOI: 10.1128/JCM.42.10.4473-4479.2004. View

11.

Haas J . Measurement of infection control department performance: state of the science. Am J Infect Control. 2006; 34(9):543-9. DOI: 10.1016/j.ajic.2005.12.001. View

12.

Sabia C, de Niederhausern S, Guerrieri E, Messi P, Anacarso I, Manicardi G . Detection of bacteriocin production and virulence traits in vancomycin-resistant enterococci of different sources. J Appl Microbiol. 2007; 104(4):970-9. DOI: 10.1111/j.1365-2672.2007.03612.x. View

13.

Eaton T, Gasson M . Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates. Appl Environ Microbiol. 2001; 67(4):1628-35. PMC: 92779. DOI: 10.1128/AEM.67.4.1628-1635.2001. View

14.

Lindenstrauss A, Pavlovic M, Bringmann A, Behr J, Ehrmann M, Vogel R . Comparison of genotypic and phenotypic cluster analyses of virulence determinants and possible role of CRISPR elements towards their incidence in Enterococcus faecalis and Enterococcus faecium. Syst Appl Microbiol. 2011; 34(8):553-60. DOI: 10.1016/j.syapm.2011.05.002. View

15.

Ekrami A, Abbasi Montazeri E, Abbas Kaydani G, Shokoohizadeh L . Methicillin Resistant Staphylococci: Prevalence and susceptibility patterns in a burn center in Ahvaz from 2013-2014. Iran J Microbiol. 2015; 7(4):208-13. PMC: 4685165. View

16.

Hallgren A, Claesson C, Saeedi B, Monstein H, Hanberger H, Nilsson L . Molecular detection of aggregation substance, enterococcal surface protein, and cytolysin genes and in vitro adhesion to urinary catheters of Enterococcus faecalis and E. faecium of clinical origin. Int J Med Microbiol. 2008; 299(5):323-32. DOI: 10.1016/j.ijmm.2008.10.001. View

17.

Sharifi Y, Hasani A, Ghotaslou R, Varshochi M, Hasani A, Soroush M . Vancomycin-resistant enterococci among clinical isolates from north-west Iran: identification of therapeutic surrogates. J Med Microbiol. 2011; 61(Pt 4):600-602. DOI: 10.1099/jmm.0.036780-0. View

18.

Shokoohizadeh L, Mobarez A, Zali M, Ranjbar R, Alebouyeh M, Sakinc T . High frequency distribution of heterogeneous vancomycin resistant Enterococcous faecium (VREfm) in Iranian hospitals. Diagn Pathol. 2013; 8:163. PMC: 3853350. DOI: 10.1186/1746-1596-8-163. View

19.

Billstrom H, Sullivan A, Lund B . Cross-transmission of clinical Enterococcus faecium in relation to esp and antibiotic resistance. J Appl Microbiol. 2009; 105(6):2115-22. DOI: 10.1111/j.1365-2672.2008.03983.x. View

20.

Sharifi Y, Hasani A, Ghotaslou R, Naghili B, Aghazadeh M, Milani M . Virulence and antimicrobial resistance in enterococci isolated from urinary tract infections. Adv Pharm Bull. 2013; 3(1):197-201. PMC: 3846047. DOI: 10.5681/apb.2013.032. View